Web Images Videos Maps News Shopping Gmail more »
Sign in
Scholar Home  
  Advanced Scholar Search
Scholar Preferences
Scholar Results 1 - 10 of about 17 citing Oshitari: Effect of Combined Antisense Oligonucleotides Against High-Glucose–and Diabetes-Induc.... (0.08 sec) 

Advanced glycation end products cause increased CCN family and extracellular …

- nih.gov
JM Hughes, EJ Kuiper, I Klaassen, P Canning, AW Stitt, … - Diabetologia, 2007 - Springer
Page 1. ARTICLE Advanced glycation end products cause increased CCN family
and extracellular matrix gene expression in the diabetic rodent retina JM Hughes
& EJ Kuiper & I. Klaassen & P. Canning & AW Stitt & J. Van Bezu ...
Cited by 18 - Related articles - BL Direct - All 7 versions

Matrix Metalloproteinase-2 Expression and Apoptogenic Activity in Retinal …


R Yang, H LIU, I WILLIAMS, B … - ANNALS-NEW YORK …, 2007 - interscience.wiley.com
Abstract : Diabetic retinopathy (DR) commences as a basement membrane disorder with a dramatic
loss of the innate retinal vascular autoregulation. In this process, retinal pericytes, which regulate
endothelial cell proliferation and survival, undergo morphometric changes consistent with ...
Cited by 17 - Related articles - BL Direct - All 5 versions

Diabetes-Enhanced Tumor Necrosis Factor-{alpha} Production Promotes …

- amjpathol.org
Y Behl, P Krothapalli, T Desta, A DiPiazza, S Roy, DT … - American Journal of …, 2008 - ASIP
Retinal microvascular cell loss plays a critical role in the pathogenesis of diabetic
retinopathy. To examine this further, type 1 streptozotocin-induced diabetic rats and type 2 Zucker
diabetic fatty rats were treated by intravitreal injection of the tumor necrosis factor-specific ...
Cited by 10 - Related articles - BL Direct - All 6 versions

Effect of VEGF-A on expression of profibrotic growth factor and extracellular matrix …

- iovs.org
EJ Kuiper, JM Hughes, RJ Van Geest, I Vogels, R … - … Ophthalmology & Visual …, 2007 - ARVO
PURPOSE. Vascular endothelial growth factor-A (VEGF) causes increased vascular permeability
and leukocyte adhesion in preclinical diabetic retinopathy (PCDR). Another hallmark of PCDR
is thickening of the capillary basement membrane (BM). Recently, VEGF has been shown ...
Cited by 9 - Related articles - BL Direct - All 2 versions

Common therapeutic strategies for diabetic retinopathy and glaucoma


T Oshitari, S Roy - Current Drug Therapy, 2007 - ingentaconnect.com
Abstract: Diabetic retinopathy and glaucoma are major diseases that cause blindness in a high
percentage of the popula- tion. However, the precise mechanisms involved in the onset and
the progression of these diseases are still not completely known. Recent studies have ...
Cited by 4 - Related articles - BL Direct

Non-viral gene therapy for diabetic retinopathy


T Oshitari - Drug Development Research, 2006 - interscience.wiley.com
Diabetic retinopathy results from vascular abnormalities, such as an increase in the permeability
of retinal vessels, and retinal neurodegeneration, which are irreversible changes that occur early
in the course of diabetic retinopathy. To block the vascular and neuronal complications ...
Cited by 3 - Related articles - BL Direct - All 3 versions

Mitochondria-and caspase-dependent cell death pathway involved in neuronal …


T Oshitari, S Yamamoto, N Hata, S Roy - British Medical Journal, 2008 - bjo.bmj.com
Methods: Immunohistochemistry was performed on cryosections obtained from five pairs of normal
and five pairs of age-matched diabetic human retinas. Diabetic eyes had no proliferative diabetic
retinopathy and no histories of photocoagulation or ocular surgery. In this study, ...
Cited by 3 - Related articles - BL Direct - All 4 versions

Connective tissue growth factor is necessary for retinal capillary basal lamina …

- jhc.org
EJ Kuiper, R van Zijderveld, P Roestenberg, … - … of Histochemistry and …, 2008 - Histochemical Soc
Experimental prevention of BL thickening ameliorated early retinal vascular changes caused
by diabetes (Roy et al. 2003 Go ; Oshitari et al. 2006 Go ). In galactose-fed rats, a model for type
2 diabetes, downregulation of fibronectin synthesis partly prevented retinal BL thickening ...
Cited by 3 - Related articles - All 7 versions

视网膜和脉络膜新生血管的基因治疗


禹海, 陈蕾 - 眼科新进展, 2007 - 万方数据资源系统
抑制视网膜或脉络膜新生血管是治疗视网膜或脉络膜血管性疾病的关键.基因治疗是目前研究的热点,
我们从动物模型、载体、治疗性靶基因的选择等方面对视网膜和脉络膜新生血管治疗的进展进行综述.
Cited by 3 - Related articles - All 4 versions

糖尿病视网膜病变的基因治疗研究进展△


袁鹏 - 眼科新进展, 2007 - cqvip.com
用户名: 密码: 登录 IP登录 用户注册/忘记密码 电子期刊阅览室 充值中心.
维普专业检索|Google学术. 题名/关键词 题名 关键词 文摘 作者 机构 刊名 分类号
参考文献 作者简介 基金资助 栏目信息 任意字段. 维普资讯. 题名/关键词; 题名; ...
Cited by 1 - Related articles - All 4 versions


Result Page: 

1

2

Next


 


Go to Google Home - About Google - About Google Scholar

©2009 Google